{
    "nct_id": "NCT05710380",
    "official_title": "Magnetic Resonance Imaging (MRI) Derived Quantitative Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy",
    "inclusion_criteria": "* Patients with known or suspected prostate cancer who have been referred for a diagnostic magnetic resonance imaging (MRI) exam of the prostate, to be followed by an MRI-guided fusion biopsy of the prostate.\n* Voluntary written informed consent before the MRI examination.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Subjects incapable of giving informed written consent.\n* Subjects who cannot adhere to the experimental protocols for any reason, or have an inability to communicate with the researcher;\n* Subjects with psychiatric disorders that affect their ability to consent for themselves will be excluded and not the entire population of patients with psychiatric disorders.\n* Prisoners.\n* Minor children (under the age of 18 years old).\n* Patients with previous treatments (surgery, radiation, focal ablation, hormone or other chemotherapy) for prostate cancer.",
    "miscellaneous_criteria": ""
}